What question did this study set out to answer?

The aim is to evaluate healthcare resource utilization, associated costs, and health-related quality of life in patients receiving systemic therapy for atopic eczema over one year.

June 17, 2026Skin Health and DiseaseOpen Access

Healthcare resource use, costs and health-related quality of life in the UK–Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study

View Full Paper

Ask AI

Bookmark

Authors

CCCarlos ChivardiUniversity of York EGElizaveta GribalevaKing's College London BCBolaji CokerGuy's and St Thomas' NHS Foundation Trust

Discussion

Member takes

Implication

Pilot study assesses costs and health-related quality of life in patients with atopic eczema, suggesting significant implications for treatment strategies.

Key Points

The aim is to evaluate healthcare resource utilization, associated costs, and health-related quality of life in patients receiving systemic therapy for atopic eczema over one year.
A multicentre prospective register recruited paediatric and adult patients initiating or switching systemic immunomodulatory therapy for atopic eczema.
Healthcare utilization was measured through GP visits, emergency department attendance, hospitalizations, and specialist consultations.
Health-related quality of life was assessed using the EuroQol 5 Dimension (EQ-5D) scale.
Adults had higher annual healthcare costs (£420.73 vs. £283.29) compared to children, including A&E, GP, and specialist visit costs.
Mean systemic therapy costs per year were £25,523 for adults and £20,242 for children.
Quality of life improved significantly, with EQ-5D scores rising from 0.608 to 0.769 in adults and from 0.482 to 0.751 in children.

Cite This Study

Chivardi et al. (2026) studied this question.

synapsesocial.com/papers/6a323d57d50b63ecad207167 https://doi.org/10.1093/skinhd/vzag042

View Full Paper

Ask AI

Bookmark

Implication

Pilot study assesses costs and health-related quality of life in patients with atopic eczema, suggesting significant implications for treatment strategies.

Healthcare resource use, costs and health-related quality of life in the UK–Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study

Discussion

Member takes

Implication

Key Points

Cite This Study

Healthcare resource use, costs and health-related quality of life in the UK–Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider